StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$2.21+0.20 (+9.95%)

Close on Nov 13, 2026Market cap $3.21MP/E –Yield –

Nexentis Technologies operating margin

Operating margin is operating income as a percentage of revenue.

Nexentis Technologies's operating margin for the twelve months ending Sep 30, 2025 was -2236.8%. For fiscal 2024 it was -1563.3%, against -2881.4% the year before. The highest annual figure on record is -121.6% in fiscal 2018.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-1563.3%+1318.0
FY2023Dec 31, 2023-2881.4%−1404.3
FY2022Dec 31, 2022-1477.1%−403.5
FY2021Dec 31, 2021-1073.5%−492.6
FY2020Dec 31, 2020-580.9%+517.5
FY2019Dec 31, 2019-1098.4%−976.9
FY2018Dec 31, 2018-121.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2025Sep 30, 2025-66300.0%−61317.6
Q1 FY2025Mar 31, 2025-762.1%+1281.1
Q4 FY2024Dec 31, 2024-155.3%+1872.6
Q3 FY2024Sep 30, 2024-15955.6%−13660.1
Q2 FY2024Jun 30, 2024-4982.4%−3541.4
Q1 FY2024Mar 31, 2024-2043.2%−1405.3
Q4 FY2023Dec 31, 2023-2028.0%+1422.6
Q2 FY2023Jun 30, 2023-2295.4%+1813.1
Q1 FY2023Mar 31, 2023-1440.9%+94.7
Q4 FY2022Dec 31, 2022-637.9%+192.4
Q3 FY2022Sep 30, 2022-3450.6%−1639.4
Q2 FY2022Jun 30, 2022-4108.5%−1126.8
Q1 FY2022Mar 31, 2022-1535.6%−1335.0
Q4 FY2021Dec 31, 2021-830.3%−740.3
Q3 FY2021Sep 30, 2021-1811.2%−1241.9
Q2 FY2021Jun 30, 2021-2981.7%−1783.3
Q1 FY2021Mar 31, 2021-200.6%+66.0
Q4 FY2020Dec 31, 2020-89.9%–
Q1 FY2020Mar 31, 2020-569.3%–
Q4 FY2019Dec 31, 2019-1198.4%–
Q1 FY2019Mar 31, 2019-266.6%–

More Nexentis Technologies figures

See a number that looks wrong?